Invasive aspergillosis after pandemic (H1N1) 2009

Emerging Infectious Diseases

Volumn 16, Issue 6, 2010, Pages 971-973

  Lat, Asma ^a   Bhadelia, Nahid ^a   Miko, Benjamin ^a   Furuya, E Yoko ^a   Thompson III, George R ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AZITHROMYCIN; AZTREONAM; CEFEPIME; FLUCONAZOLE; LINEZOLID; METHYLPREDNISOLONE; METRONIDAZOLE; MICAFUNGIN; OSELTAMIVIR; TOBRAMYCIN; VANCOMYCIN; VORICONAZOLE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHOSCOPY; CARDIOPULMONARY ARREST; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FATALITY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INTUBATION; INVASIVE ASPERGILLOSIS; KIDNEY FAILURE; LUNG BIOPSY; LUNG CONGESTION; LUNG HEMORRHAGE; LYMPHOCYTOPENIA; MALE; PANDEMIC; PNEUMONIA; POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE;

ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FATAL OUTCOME; GLUCOCORTICOIDS; HUMANS; IMMUNOCOMPETENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; TIME FACTORS;

EID: 77952696530     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1606.100165     Document Type: Article

References (15)

1. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327-60. DOI: 10.1086/525258
2. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30:782-800. DOI: 10.1183/09031936.00062206
3. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004;170:621-5. DOI: 10.1164/rccm.200401-093OC
4. Chen TK, Babbitt CJ, Maggi C, Abbosaida A, Randhawa I, Walsh TJ. Pulmonary aspergillosis following H1N1 influenza A infection in pediatric patients. In: Programs and Abstracts of the 20th Annual Focus on Fungal Infections. New Orleans, LA: 2010 Mar 3-5. Alpharetta (GA): Imedex, LLC. Poster P-0026.
5. Lewis DE, Gilbert BE, Knight V. Influenza virus infection induces functional alterations in peripheral blood lymphocytes. J Immunol. 1986;137:3777-81.
6. Sedger LM, Hou S, Osvath SR, Glaccum MB, Peschon JJ, van Rooijen N, et al. Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha. J Immunol. 2002;169:6193-201.
7. Lewis M, Kallenbach J, Ruff P, Zaltzman M, Abramowitz J, Zwi S. Invasive pulmonary aspergillosis complicating influenza A pneumonia in a previously healthy patient. Chest. 1985;87:691-3. DOI: 10.1378/chest.87.5.691
8. Fischer JJ, Walker DH. Invasive pulmonary aspergillosis associated with influenza. JAMA. 1979;241:1493-4. DOI: 10.1001/jama.241.14.1493
9. Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest. 1998;114:629-34. DOI: 10.1378/chest.114.2.629
10. Boots RJ, Paterson DL, Allworth AM, Faoagali JL. Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax. 1999;54:1047-9. DOI: 10.1136/thx.54.11.1047
11. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporealv membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA. 2009;302:1888-95. DOI: 10.1001/jama.2009.1535
12. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010;50:850-9. DOI: 10.1086/650581
13. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671-84. DOI: 10.1056/NEJMoa051693
14. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302:1896-902. DOI: 10.1001/jama.2009.1583
15. Dutkowski R. Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. J Antimicrob Chemother. 2010;65(Suppl 2):ii11-24. DOI: 10.1093/jac/dkq012